Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus
Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus
Not yet recruiting · NCT06965244 · Registry updated 2025-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, cutaneous lupus erythematosus, immune system disorder, skin disorder, systemic lupus erythematosus | Not yet recruiting | Phase 3 | 2025-05-11 | NCT06965244 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||